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Osteopetrosis  is a rare  hereditary  disease  characterized  by  osteoclast  dysfunction  and  consequently
diminished  bone resorption  and  disturbed  bone  building  and  remodeling,  resulting  in  abnormally  dense
and  brittle  bones.  Pathologic  fractures  are  common  in  patients  with  osteopetrosis.  We  report  a case of
benign  adult  form  of  osteopetrosis  with  severe  aortic stenosis  (AS)  and  coronary  artery  disease  (CAD).
A  67-year-old  female  patient  presented  with  long-standing  dyspnea  and  palpitation.  She  was  diagnosed
with  benign  adult  form  of osteopetrosis  in  her childhood,  upon  detailed  investigations  for  a  pathologic
fracture.  Physical  examination  and  imaging  studies  revealed  severe  AS  and  two-vessel  CAD.  Aortic  valve
replacement  and coronary  artery  bypass  grafting  were  indicated,  but  open  heart  surgery  by  median
sternotomy  was  high  risk  because  of osteopetrosis.  We  performed  staged  percutaneous  coronary  inter-
vention  (PCI)  and  transcatheter  aortic  valve  implantation  (TAVI)  as  minimally  invasive  treatment.  The
postoperative  course  was  uneventful  and  transthoracic  echocardiography  showed  a properly  functioning
prosthetic  valve  and  no sign  of  AS. This  is the  ﬁrst  case  report  of  successful  treatment  of  severe  AS and
CAD  by combined  TAVI  and  PCI  in  a patient  with  osteopetrosis.
<Learning objective:  Transcatheter  aortic  valve  implantation  (TAVI)  has  become  available  for  the  treat-
ment  of aortic  stenosis  (AS).  In  osteopetrosis  patients,  protraction  of bone  healing  is  expected  after  open
heart  surgery.  Despite  standard  risk  scoring  showing  AS  to be low  risk,  osteopetrosis  may  beneﬁt  largely
from  TAVI.>
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Osteopetrosis refers to a group of disorders characterized by
efects in osteoclastic function resulting in defective bone resorp-
ion [1]. Despite increased bone density observable by radiography,
here is an increased incidence of fracture [2] and problem with
racture healing [3]. Thus a patient with osteopetrosis is consid-
red high-risk for thoracotomy, because protraction of bone healing
s expected. Recently, even for high-risk inoperable patients with
evere aortic stenosis (AS), transcatheter aortic valve implantation
TAVI) has become available as an effective treatment modality and
 novel alternative approach [4].
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We present a case of osteopetrosis with severe AS and coronary
artery disease (CAD) successfully treated by TAVI and percutaneous
coronary intervention (PCI).
Case report
A  67-year-old female patient presented with dyspnea (New
York Heart Association functional class II) and palpitation over
the previous two  years without angina or syncope. She was
diagnosed with osteopetrosis in her childhood after sustaining
a pathologic fracture in her right femur. Her elder sister was
also diagnosed with osteopetrosis. Laboratory ﬁndings showed no
signiﬁcant abnormalities. Auscultation detected Levine grade 3/6
ejection systolic murmur over the right sternal edge. Chest X-ray
showed generalized increase in bone density (Fig. 1). Transthoracic
echocardiography (TTE) revealed severe AS and a severely calci-
ﬁed tri-leaﬂet valve. Her aortic valve area was 0.56 cm2 (continuity
vier Ltd. All rights reserved.
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(Fig. 1. Chest radiography. Note generalized increase in bone density.
quation), peak ﬂow velocity was 6.3 m/s, mean pressure gradi-
nt was 74 mmHg, and left ventricular ejection fraction was 66%.
lanimetry of the aortic valve oriﬁce by transesophageal echocar-
iography (TEE) gave an area of 0.47 cm2 (Fig. 2A and B). The
tandard TEE measurements were as follows: aortic valve annulus,
1 mm;  aorta at the level of sinuses of Valsalva, 24 mm;  sinotubular
unction, 22 mm;  and ascending aorta, 34 mm.  Diagnostic coro-
ary angiography revealed two-vessel disease with severe stenosis
n the proximal left anterior descending artery (LAD) and right
oronary artery (RCA). Aortic valve replacement (AVR) and coro-
ary artery bypass grafting (CABG) were indicated. Her logistic
uroSCORE was 3.5% and STS Score was 2.0%. However, open heart
urgery via a median sternotomy was anticipated to be high risk
ecause of osteopetrosis. As an alternative, we performed mini-
ally invasive treatment by PCI and TAVI.
ig. 2. Transesophageal echocardiography: long-axis view (A) and short-axis view
B). Aortic valve is severely calciﬁed and aortic valve area is 0.47 cm2 (planimetry).gy Cases 8 (2013) 113–115
First, signiﬁcant coronary stenosis was treated with two  bare-
metal stents (BMS). After one month, severe AS was treated with
TAVI (Fig. 3). We  chose a 23-mm Edwards-Sapien XT bioprosthe-
sis (Edwards Lifescience, Irvine, CA, USA) according to the valve
manufacturer’s instructions. TAVI was performed under general
anesthesia by standard procedures via a transfemoral approach
with TEE guidance.
Balloon  dilation of the native aortic valve and consequent
implantation of the prosthetic valve under rapid pacing were
uneventful. At the end of the TAVI procedure, pressure gradient
across the aortic valve was 0 mmHg  (Fig. 4A and B) with only mild
aortic regurgitation. The patient was extubated on the day of the
procedure and stayed for one day in the intensive care unit. The
patient underwent surgical repair of right femoral artery steno-
sis due to percutaneous arterial suture device (Perclose; Abbott,
Abbott Park, IL, USA) 10 days after the TAVI. She was  discharged
16 days after the TAVI procedure. On the 30-day post-discharge
follow-up, the patient had no symptoms and TTE showed a properly
functioning prosthetic valve.
Discussion
We describe an osteopetrosis patient with severe AS and
CAD treated with TAVI and PCI as minimally invasive treat-
ment. Osteopetrosis is a hereditary bone disease characterized
by osteoclast failure and impaired bone resorption [5]. There are
three clinically distinct phenotypes of osteopetrosis: the infantile
malignant autosomal recessive form, the intermediate autoso-
mal recessive form, and the adult benign autosomal dominant
form [2]. Many patients present with fractures related to brit-
tle osteopetrotic bones, or with osteomyelitis, however AS as a
complication of osteopetrosis has not been documented [5]. In
these patients, protraction of bone healing is expected after open
heart surgery. It may  not be a signiﬁcant problem for middle-aged
patients. Therefore median sternotomy is not an absolute con-
traindication in patients with osteopetrosis. However, combined
TAVI and PCI can avoid this problem completely.
Combined AVR and CABG remains the standard treatment for
patients with AS and CAD at present. However, combined TAVI and
PCI has been proposed theoretically for the treatment of high-risk
patients [6]. Nevertheless, reports of efﬁcacy of this treatment are
limited to case reports [7].
Fig. 3. Fluoroscopy during transcatheter aortic valve implantation. Balloon dilata-
tion of the aortic valve during rapid right ventricular pacing.
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[ig. 4. Polygraphy of intracardiac pressure and intraaortic pressure: before transc
radient between left ventricle (LV) and aorta (AO) improved from 51 to 0 mmH
lectrocardiogram.
We  discussed not only TAVi via a transfemoral approach but also
inimally invasive cardiac surgery (MICS) and TAVI via transapi-
al approach to perform the optimal therapy for this patient with
ur heart team. However, both MICS and TAVI via a transapical
pproach are anterior mini-thoracotomy at the intercostal space
nder constant tension. We  considered that speciﬁc risks of fracture
xist for these approaches. Finally, we selected minimally invasive
reatment by TAVI via a transfemoral approach.
This is the ﬁrst case report of successful treatment of severe AS
nd CAD by combined TAVI and PCI in a patient with osteopetrosis.
espite standard risk scoring showing AS to be low risk, osteopet-
osis may  beneﬁt largely from TAVI.onﬂict of interest
Authors  declare no conﬂict of interest.
[
[er aortic valve implantation (TAVI) (A) and after TAVI (B). Simultaneous pressure
er TAVI. ECG showed bundle branch block transiently after the procedure. ECG,
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